drugset / Trial / NCT06483789
Efficacy and Safety of HB-1 for Panic Disorder
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine the safety and efficacy of HB-1, versus placebo and two monotherapies, in male and female adult patients aged 18 to 65 years, inclusive, with Panic Disorder.
Timeline
- Start
- 2024-10-29
- Primary completion
- 2026-09-09
- Completion
- 2026-09-09
Outcome
Outcome not reported
Stopped: “Decision to terminate study due to a lack of efficacy in this study population. There were no safety concerns identified that contributed to this decision.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Telmisartan | Other / unclassified | — | Oral |
| Subject | Verapamil | Other / unclassified | — | Oral |